Annual Drug Patent Expirations for LUMRYZ
Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
This drug has twenty-four patent family members in ten countries.
The generic ingredient in LUMRYZ is sodium oxybate. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com